Skip to content

The influence of oral Ginger on nausea and vomiting after cataract surgery

The influence of oral Ginger before operation on nausea and vomiting after cataract surgery under general anesthesia: A double-blind placebo-controlled randomized clinical trial.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015062122853N1
Enrollment
129
Registered
2016-08-18
Start date
2015-06-15
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cataract. Combined forms of senile cataract

Interventions

Intervention 1: Intervention group 2: the patients were given two capsules each of them 500 mg ginger at 10 p.m. and 6 a.m. before the operation. Intervention 2: Control group: the patients were given
Treatment - Drugs
Intervention group 2: the patients were given two capsules each of them 500 mg ginger at 10 p.m. and 6 a.m. before the operation.
Control group: the patients were given a placebo capsule similar to capsules each of them 500 mg ginger at 6 a.m. before the operation.
intervention group1: the patients were given two capsules each of them 500 mg ginger at 6 a.m. before the operation

Sponsors

Vice Chancellor for research and technology of Kurdistan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria included; surgical candidates; volunteered to participate in the study; lack of underlying medical conditions (diabetes, chronic respiratory disease, chronic heart disease, kidney disorders, liver kidney disorders, kidney disorders, dementia, Alzheimer's disease and other acute or chronic disorders);Lack of preoperative nausea and vomiting; is to using general anesthesia with a specific drugs including propofol or thiopental. Exclusion criteria included Patient’s withdrawal from the research, cancel surgery, and unpredicted events during surgery such as cardiac arrest or patient’s death

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: From the moment of admission to recovery up to six hours after surgery. At the moment of admission to the ward after surgery and at 2, 4, and 6 hours after admission to the ward. Method of measurement: Incidences of pain are recorded in the information sheet. Based on Visual Analog Scale (VAS) as standard tool; severity of pain is rated from zero to ten.;Nausea. Timepoint: From the moment of admission to recovery up to six hours after surgery. At the moment of admission to the ward after surgery and at 2, 4, and 6 hours after admission to the ward. Method of measurement: Incidences of nausea are recorded in the information sheet. Based on Visual Analog Scale (VAS) as standard tool; severity of nausea is rated from zero to ten.;Vomiting. Timepoint: From the moment of admission to recovery up to six hours after surgery. At the moment of admission to the ward after surgery and at 2, 4, and 6 hours after admission to the ward. Method of measurement: Incidence of vomiting is recorded in the information sheet.

Secondary

MeasureTime frame
-. Timepoint: -. Method of measurement: -.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSimin Nazarian

Kurdistan University of medical sciences

Sara_nazarian@yahoo.comNazarian.simin@muk.ac.ir+98 87 3182 7474

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Mar 11, 2026